Icosavax

Icosavax is a biotechnology company developing synthetic vaccines, originating as a spinout from the University of Washington Institute...

Facts

HQ: Seattle
Sectors: Biotechnology, Vaccines, Biotech
Stage: Public
Total raised: $129.7M SEC Form D filings Total of this company's SEC Form D filings
Last round: $99.7M · Mar 2021 SEC Form D

Completed an acquisition or disposition Feb 20, 2024 SEC Form 8-K
Leadership or executive-pay change Feb 20, 2024 SEC Form 8-K
Signed a material agreement Dec 12, 2023 SEC Form 8-K
Signed a material agreement May 23, 2023 SEC Form 8-K
Leadership or executive-pay change Feb 11, 2022 SEC Form 8-K
Leadership or executive-pay change Jan 5, 2022 SEC Form 8-K
Signed a material agreement Dec 16, 2021 SEC Form 8-K
Filed to go public Jul 7, 2021 SEC Form S-1
Raised $99.7M Mar 19, 2021 SEC Form D
Raised $30M Aug 15, 2019 SEC Form D